Figures show 28 % of uk UK patient groups have a positive proportion of pharmaceutical firms , attributable to only 43 % of companies partnering with them , compared to the global figure of 81 % , according to a report by PatientView . The participants criticised the sector for a lack of transparency regarding pricing policies , clinical data sharing and the funding of external stakeholders , and called for a more patient - centric approach .
Figures show 28% of 111 UK patient groups have a positive impression of pharma firms, attributable to only 43% of groups partnering with them, compared to the global figure of 81%, according to a report by PatientView. The participants criticised the sector for a lack of transparency surrounding pricing policies, clinical data sharing and the funding of external stakeholders, and called for a more patient-centric approach.